Target intelligence / Profile preview

Immunoglobulin heavy diversity 5-18 (IGHD5-18)

Target
IGHD5-18
Molecular classification
Other (Immunoglobulin gene segment)
01

Overview

Immunoglobulin heavy diversity 5-18 (IGHD5-18) is one of several DH (diversity heavy) gene segments located within the immunoglobulin heavy-chain (IGH) locus on human chromosome 14. DH segments are required for the assembly of variable regions of immunoglobulins during V(D)J recombination in developing B cells. This process allows the immune system to generate a highly diverse repertoire of antibodies, which is central to adaptive immunity. IGHD5-18 itself is not a protein or receptor; rather, it is a short DNA sequence that gets recombined together with IGHV (heavy variable) and IGHJ (heavy joining) gene segments to form a unique variable domain coding sequence for the immunoglobulin heavy chain[1][2][3][5]. This genetic recombination is necessary for generating antibody diversity but does not make IGHD5-18 a therapeutic target. Key details: - IGHD5-18 is a DH segment, meaning its biological role is to contribute to variable domain diversity in immunoglobulin heavy chains through genetic recombination[1][5]. - It is not expressed as a standalone protein, receptor, or functional entity. - No drugs or biomarker applications target IGHD5-18 specifically. - Not associated with safety concerns or therapeutic strategies. If you seek information about therapeutic targets, focus on the immunoglobulin proteins produced via V(D)J recombination or the receptors/enzymes that mediate these processes, rather than DH gene segments themselves.

Other names
IGHD5-18IGHD518
02

Biological functions

Generation of antibody diversityImmune repertoire formation
03

Disease associations

Other (Indirectly involved in immunodeficiency, lymphoid malignancies, or autoimmune disorders via its role in antibody gene rearrangement, but not as a direct therapeutic target)

Beyond the preview

Go deeper on Immunoglobulin heavy diversity 5-18 (IGHD5-18).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Immunoglobulin heavy diversity 5-18 (IGHD5-18).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call